key: cord-0824087-05xxsjxl
authors: Trisnawati, Ika; El Khair, Riat; Puspitarani, Dyah Ayu; Fauzi, Aditya Rifqi; Gunadi
title: Prolonged nucleic acid conversion and false-negative RT-PCR results in patients with COVID-19: A case series
date: 2020-10-06
journal: Ann Med Surg (Lond)
DOI: 10.1016/j.amsu.2020.09.040
sha: 3895d8f70922f5594a535faa1f674051fd56a69b
doc_id: 824087
cord_uid: 05xxsjxl

BACKGROUND: Prolonged nucleic acid conversion and false-negative results of real-time polymerase chain reaction (RT-PCR) might occur in COVID-19 patients rather than infection recurrence. PRESENTATION OF CASES: We reported four cases who had negative RT-PCR results, in addition to the last two consecutive negative results. Patient-1 had negative RT-PCR results twice (the 6th and 8th) from a total of 11 swabs. Patient-2 had negative RT-PCR results once (the 5th) from a total of 8 swabs. Patient-3 showed negative results of RT-PCR twice (the 4th and 6th) from a total of 11 swabs. Patient 4 had negative RT-PCR results twice (the 2nd and 10th) from a total of 14 swabs. DISCUSSION: The fluctuating trend of our RT-PCR results in our cases might be due to insufficient viral material in the specimen, laboratory errors during sampling, restrictions on sample transportation, or mutations in the primary and probe target regions in the SARS-CoV-2 genome. Several factors might affect the occurrence of prolonged nucleic acid conversion, including older age, comorbidities, such as diabetes and hypertension, and impaired immune function. CONCLUSION: Here, we confirmed the occurrence of prolonged nucleic acid conversion and the possibility of false negative RT-PCR results in COVID-19.

In December 2019, an outbreak of infection of severe acute respiratory syndromecoronavirus-2 (SARS-CoV-2) was detected in Wuhan, China. This virus has the etiology of Coronavirus disease 2019 , first announced by the World Health Organization (WHO) on January 12, 2020, and now becomes a global pandemic [1, 2] .

The length of the virus incubation period is approximately five days [3] . Several studies [4, 5] reported a median length of viral shedding between 12-20 days from the onset of symptoms. Previously, cases of prolonged nucleic acid conversion have also been reported, with the longest reported being 60 days [6] . Nucleic acid conversion is defined as the period from the date of symptom onset to the date of the first negative real-time reverse transcription polymerase chain reaction (RT-PCR) test result [7] . It has been hypothesized that prolonged nucleic acid conversion and false negative results of RT-PCR occur in some patients with COVID-19 rather than recurrence of infection [7] . Here, we report four cases of COVID-19 with the possibility of prolonged nucleic acid conversion and false negative results of RT-PCR in our institution, Indonesia. This case series has been reported in line with the PROCESS criteria [8] .

normal results on his remaining vital signs. Lung auscultation revealed no apparent abnormality. Chest X-rays showed the appearance of mild pneumonia in the right lung ( Fig. 1) . Blood tests showed an increase in the neutrophil-lymphocyte ratio (NLR) of 2.03 and C-reactive protein (CRP) of 10 mg/L. After admission, the patient received antibiotics and antiviral therapy based on the COVID-19 Prevention and Control guidelines by the Indonesian Ministry of Health, namely, azithromycin, hydroxychloroquine, oseltamivir, lopinavir-ritonavir, and umifenovir. SARS-CoV-2 retesting with nasopharyngeal and oropharyngeal swabs was performed with positive results in the 3 rd until 5 th test. In the 6 th swab, the results were negative but were positive in the 7 th swab. In the 8 th swab, the results returned negative but were positive in the 9 th swab. Two consecutive negative results were found on the 10 th and 11 th swabs. The patient was discharged from the hospital on April 25, 2020, 31 days after the onset of illness (Table 1) .

A 54-year-old male patient complained of shortness of breath that worsened with activity.

The patient began experiencing fever nine days before admission. Three days before admission, he experienced a cough with phlegm. He had a history of contact with a confirmed case of COVID-19 two weeks before admission. He had a comorbidity of diabetes controlled with routine medication. The physical examination recorded blood pressure of 131/72 mmHg, pulse of 96 per minute, respiratory rate of 24 per minute, body temperature of 38°C, and oxygen saturation of 97% with oxygenation of 2 liters per minute using nasal cannula. Lung auscultation revealed no apparent abnormality. Rapid J o u r n a l P r e -p r o o f diagnostic tests using SARS-CoV-2 antibody were performed and showed nonreactive results. Chest X-rays showed inhomogeneous opacity on bilateral paracardial and lateral aspects, typical of viral pneumonia caused by COVID-19 infection (Fig. 2) . We found increases in the NLR and CRP of 2.94 and 107 mg/L, respectively. After admission, the patient received antibiotics and antiviral therapy based on the COVID-19 Prevention and Control guidelines by the Indonesian Ministry of Health, namely, azithromycin, hydroxychloroquine, and lopinavir-ritonavir. On the following day, naso/oropharyngeal swabs were performed with positive results. On the fifth day of treatment, naso/oropharyngeal swabs were performed again, and the results were still positive, even though his symptoms were relieved. Positive PCR results were found until the 4 th test but were negative on the 5 th test, turned positive again on the 6 th , and then two consecutive results were found to be negative on the 7 th and 8 th tests (Table 1 ). The patient was discharged uneventfully after 29 days of treatment.

A 47-year-old man presented with complaints of fever, cough, sore throat, and diarrhea that were experienced from 10 days before admission. The patient has comorbidities of asthma and heart rhythm disorders in the form of ventricular extra systole. He had a history of penicillin allergy. His vital signs are within normal limits. Lung auscultation revealed crackles in both lungs. Rapid diagnostic tests using SARS-CoV-2 antibodies were performed and showed reactive results. Chest X-rays showed bilateral pneumonia (Table 1 ). The patient was discharged uneventfully after 52 days of treatment.

A 56-year-old woman came to the emergency department with complaints of lethargy that worsened in the last 6 days before admission. Her complaints included diarrhea daily more than 10 times, without mucus or blood. The patient also experienced fever for 4 days before admission. The patient went to a private hospital, was hospitalized for 4 days, and was referred to our hospital for further tracking related to her neutropenia condition.

She has a history of hyperthyroidism that she had suffered from for the past 1.5 months and has received 100 mg twice daily PTU therapy and thiamazole 5 mg once daily. She (Table 1) . Two consecutive negative results were obtained on the 13 th and 14 th swabs ( Table 1 ). The patient was discharged uneventfully after 70 days of treatment.

(Insert Table 1 here)

We report the occurrence of prolonged nucleic acid conversion and the possibility of false negative RT-PCR test results of SARS-Cov-2 from Indonesian patients with COVID-19. To the best of our knowledge, our case is the longest prolonged nucleic acid conversion reported being 70 days. Prolonged nucleic acid conversion is defined as conversion for more than 24 days from the onset of the typical symptoms of COVID-19 [7] . Interestingly, previous studies have reported that symptomatic and asymptomatic patients have the same viral loads, showing that there is a potential for transmission from J o u r n a l P r e -p r o o f patients without or with mild symptoms [9, 10] . Our cases recovered from mild symptoms of COVID-19 but experienced an extended duration of viral shedding. Moreover, during treatment in the hospital, our cases showed negative results between the positive results of RT-PCR. This finding is similar to previous reports [7, 11, 12] , which reported the high false negative rate of RT-PCR for COVID-19 detection. The fluctuating trend of our RT-PCR results in our cases might be due to insufficient viral material in the specimen, laboratory errors during sampling, restrictions on sample transportation [11] , or mutations in the primary and probe target regions in the SARS-CoV-2 genome [13] .

RT-PCR is indeed a "gold standard" diagnosis of COVID-19 because it detects RNA but not the active infectious virus. A virus culture study by Bullard et al. [14] reported that virus infectivity decreased significantly when RT-PCR cycle threshold (C T ) values were > 24. C T values of RT-PCR tests are inversely related to viral load. For every 1 unit increase in C T , the odds ratio for infectivity decreases by 32%. Some studies also reported that viral infectivity in patients with a symptom duration > 8 days may be low [14, 15] . Several factors might affect the occurrence of prolonged nucleic acid conversion, including older age, comorbidities, such as diabetes and hypertension, and impaired immune function [16] . Our cases, except patient #1, had comorbidities, such as diabetes, hyperthyroid, asthma and arrhythmia.

Previously, on January 12, 2020, the WHO recommended that COVID-19 patients be discharged from isolation when the patients are clinically recovered and show two negative RT-PCR results on sequential samples taken at least 24 hours apart [17] . On May 27, 2020, WHO revised the recommendation for discharging COVID-19 patients from isolation without requiring retesting of RT-PCR: a) for symptomatic patients: 10 J o u r n a l P r e -p r o o f days after symptom onset, plus at least 3 additional days without symptoms (including without fever and without respiratory symptoms); b) for asymptomatic cases: 10 days after positive test of RT-PCR for SARS-CoV-2 [18] . Since August 1, 2020, our government has already adopted these recommendations for the management of patients with COVID-19 in Indonesia, except for patients with severe COVID-19: the criteria for discharging patients from isolation needs a negative RT-PCR result [19] .

Positive RT-PCR results in COVID-19 patients address the detection of the presence of SARS-CoV-2 RNA, but, this does not essentially mean that a patient is infectious and able to transmit the virus to another person [18] . Several studies have shown that SARS-CoV-2 is unable to be cultured from the respiratory tract swabs of COVID-19 patients after 7-9 days of symptom onset [14, 20, 21] .

The limitation of our study is the small sample size of COVID-19 cases with prolonged nucleic acid conversion and the possibility of false-negative RT-PCR results.

These facts should be considered during the interpretation of our case series.

Our cases further confirmed the occurrence of prolonged nucleic acid conversion and the possibility of false negative RT-PCR results in patients with COVID-19 instead of recurrence of infection.

No potential conflict of interest relevant to this article was reported.

J o u r n a l P r e -p r o o f

Written informed consent was obtained from the patient for publication of this case series and accompanying images. A copy of the written consent forms is available for review by the Editor-in-Chief of this journal on reasonable request.

Not commissioned, externally peer reviewed. 

The novel coronavirus originating in Wuhan, China: challenges for global Health Governance

The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application

Duration of SARS-CoV-2 viral shedding during COVID-19 infection

Factors associated with prolonged viral RNA shedding in patients with COVID-19

Case report: viral Shedding for 60 Days in a woman with COVID-19

False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence

for the PROCESS Group. The PROCESS 2018 Statement: Updating Consensus Preferred Reporting Of CasE Series in Surgery (PROCESS) Guidelines

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Transmission of 2019-nCoV infection from an asymptomatic contact in Germany

Stability issues of RT PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19

Positive RT-PCR test results in patients recovered from COVID-19

Real-time RT-PCR in COVID-19 detection: issues affecting the results

Predicting infectious SARS-CoV-2 from diagnostic samples

Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19

Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients

World Health Organization. Laboratory testing of human suspected cases of novel coronavirus (nCOV) infection (Interim Guidance

World Health Organization. Clinical management of COVID-19

Guideline for prevention and management of COVID-19 (Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19) Revisi Ke-5) file:///Users/drgunadi/Downloads/REV-05_Pedoman_P2_COVID-19_13_Juli_2020%20(1).pdf

Virological assessment of hospitalized patients with COVID-19

Symptom-Based Strategy to Discontinue Isolation for Persons with COVID-19

The following information is required for submission. Please note that failure to respond to these questions/statements will mean your submission will be returned. If you have nothing to declare in any of these categories then this should be stated.

All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.No potential conflict of interest relevant to this article was reported Please state any sources of funding for your research All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.The authors declare that this study had no funding source.

Research studies involving patients require ethical approval. Please state whether approval has been given, name the relevant ethics committee and the state the reference number for their judgement.The informed consent form was declared that patient data or samples will be used for educational or research purposes. Our institutional review board also do not provide an ethical approval in the form of case series.J o u r n a l P r e -p r o o f Consent Studies on patients or volunteers require ethics committee approval and fully informed written consent which should be documented in the paper.Authors must obtain written and signed consent to publish a case report from the patient (or, where applicable, the patient's guardian or next of kin) prior to submission. We ask Authors to confirm as part of the submission process that such consent has been obtained, and the manuscript must include a statement to this effect in a consent section at the end of the manuscript, as follows: "Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request".Patients have a right to privacy. Patients' and volunteers' names, initials, or hospital numbers should not be used. Images of patients or volunteers should not be used unless the information is essential for scientific purposes and explicit permission has been given as part of the consent. If such consent is made subject to any conditions, the Editor in Chief must be made aware of all such conditions. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request

Please specify the contribution of each author to the paper, e.g. study concept or design, data collection, data analysis or interpretation, writing the paper, others, who have contributed in other ways should be listed as contributors. 

In accordance with the Declaration of Helsinki 2013, all research involving human participants has to be registered in a publicly accessible database. Please enter the name of the registry and the unique identifying number (UIN) of your study.You can register any type of research at http://www.researchregistry.com to obtain your UIN if you have not already registered. This is mandatory for human studies only. Trials and certain observational research can also be registered elsewhere such as: ClinicalTrials.gov or ISRCTN or numerous other registries.researchregistry5709

The Guarantor is the one or more people who accept full responsibility for the work and/or the conduct of the study, had access to the data, and controlled the decision to publish Ika Trisnawati and Gunadi J o u r n a l P r e -p r o o f